Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lesley G Shane"'
Autor:
Kyle Paret, Hadi Beyhaghi, William L. Herring, Josephine Mauskopf, Lesley G. Shane, Matthew D. Rousculp
Publikováno v:
Vaccines, Vol 12, Iss 1, p 74 (2024)
Policymakers in the United States (US) recommend coronavirus disease 2019 (COVID-19) vaccination with a monovalent 2023–2024 vaccine formulation based on the Omicron XBB.1.5 variant. We estimated the potential US population-level health and economi
Externí odkaz:
https://doaj.org/article/e8b333a752214a469c78608b9b99c121
Publikováno v:
Journal of Oncology Pharmacy Practice
BackgroundPatients with cancer have an elevated risk of venous thromboembolism. Importantly, patients with cancer, who have metastatic disease, renal insufficiency, or are receiving anticancer therapy, have an even higher risk of a recurrent event. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9348e4f24450b8b9d6fc16343529c801
https://doi.org/10.1177/1078155217727140
https://doi.org/10.1177/1078155217727140
Publikováno v:
Value in Health. 23:S14-S15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60fb415baf0f42ad5812d92d548d42f8
https://doi.org/10.1016/j.jval.2020.04.075
https://doi.org/10.1016/j.jval.2020.04.075
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Due to the continued increase in global spending on health care, payers have introduced a number of programs, policies, and agreements on pharmaceutical pricing in order to control costs. While incentives to increase generic drug use have achieved si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8db69712aee3da89e64d5a8d9b82d28
https://pubmed.ncbi.nlm.nih.gov/29033595
https://pubmed.ncbi.nlm.nih.gov/29033595
Publikováno v:
Pharmacoeconomics
Biosimilar drugs are highly similar to an originator (reference) biologic, with no clinically meaningful differences in terms of safety or efficacy. As biosimilars offer the potential for lower acquisition costs versus the originator biologic, evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db446a99ec8f10ded946117b1d5cede
https://lirias.kuleuven.be/handle/123456789/599756
https://lirias.kuleuven.be/handle/123456789/599756
Publikováno v:
The Annals of pharmacotherapy. 51(7)
Objective: To review the scientific and regulatory aspects of biosimilar development and practical considerations for the use of biosimilars that are relevant to pharmacists. Data Sources: Literature searches of PubMed and congress abstracts for publ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ffaf04d257e341642d357f1e9ee6ab
https://pubmed.ncbi.nlm.nih.gov/28176529
https://pubmed.ncbi.nlm.nih.gov/28176529
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
George Dranitsaris,1 Lesley G Shane,2 Mark Crowther,3 Guillaume Feugere,4 Seth Woodruff2 1Health Economic and Outcomes Research, Augmentium Pharma Consulting Inc, Toronto, ON, Canada; 2Pfizer Inc, New York, NY, USA; 3McMaster University, Hamilton, ON
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7209bb89afd5bb140d653e21d2ddf95e
https://www.dovepress.com/dalteparin-versus-vitamin-k-antagonists-for-the-prevention-of-recurren-peer-reviewed-article-CEOR
https://www.dovepress.com/dalteparin-versus-vitamin-k-antagonists-for-the-prevention-of-recurren-peer-reviewed-article-CEOR
Autor:
Seth Woodruff, Lesley G Shane, Gunar Stemer, Jean-Philippe Galanaud, Philippe Debourdeau, George Dranitsaris
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 25(7)
International guidelines recommend extended duration secondary prophylaxis in cancer patients who develop primary venous thromboembolism (VTE). Agent selection is guided in part by one large randomized trial (i.e., CLOT; Lee et al., N Engl J Med 349:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2729a659aca81719fc491b47048a05fb
https://pubmed.ncbi.nlm.nih.gov/28204995
https://pubmed.ncbi.nlm.nih.gov/28204995
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 22(7)
Background: In a randomized trial (ie, Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer [CLOT]) that evaluated secondary prophylaxis of recurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685a4d7f5eff78cb00217e8e4f39f4c4
https://pubmed.ncbi.nlm.nih.gov/27436663
https://pubmed.ncbi.nlm.nih.gov/27436663
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ac6d23123cfb81f9c3acea5281c5ba